STOCK TITAN
  1. Home
  2. Sec-filings
  3. IBO
  4. [PRE 14C] Impact BioMedical, Inc. Preliminary Information Statement

[PRE 14C] Impact BioMedical, Inc. Preliminary Information Statement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
PRE 14C

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock IBO logo
Impact Biomedical, Inc.

NYSE:IBO

IBO Rankings

#6244 Ranked by Market Cap
N/A Ranked by Dividends

IBO Latest News

Aug 18, 2025
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
Jun 23, 2025
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
Mar 21, 2025
Impact Biomedical Inc. Announcement Stock Activity/Pricing
Feb 26, 2025
Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room Air Quality”
Jan 23, 2025
Impact BioMedical Inc. to Present at The Microcap Conference

IBO Latest SEC Filings

Sep 9, 2025
[DEF 14C] Impact BioMedical, Inc. Definitive Information Statement
Aug 26, 2025
[PRE 14C] Impact BioMedical, Inc. Preliminary Information Statement
Aug 14, 2025
[10-Q] Impact BioMedical, Inc. Quarterly Earnings Report
Aug 5, 2025
[DEF 14C] Impact BioMedical, Inc. Definitive Information Statement
Jun 23, 2025
[8-K] Impact BioMedical, Inc. Reports Material Event

IBO Stock Data

8.02M
11.72M
5.17%
4.17%
2.62%
Biotechnology
Pharmaceutical Preparations
Link
United States
HOUSTON